Facial angiofibromas of tuberous sclerosis treated with topical sirolimus in an Indian patient
Facial angiofibromas are the most visible and unsightly of all the cutaneous manifestations of tuberous sclerosis (TSC). A 17-year-old female, a known case of TSC, presented for the treatment of cosmetically disfiguring facial angiofibromas. She was started on twice daily application of 0.1% sirolim...
Saved in:
Main Author: | Resham J Vasani (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topical rapamycin (sirolimus) for facial angiofibromas
by: Bhushan Madke
Published: (2013) -
Isolated unilateral facial angiofibroma or segmental tuberous sclerosis complex?
by: Bhagyashree B Supekar, et al.
Published: (2021) -
Dermoscopy of Facial Angiofibromas in Four Patients of Skin of Color with Tuberous Sclerosis Complex: A Case-Series
by: Rashmi Jindal, et al.
Published: (2021) -
Use of topical rapamycin in facial angiofibromas in Indian skin type
by: Vishalakshi Viswanath, et al.
Published: (2016) -
Effective Technique Using Combined CO2 Laser and Pulsed Dye Laser for Facial Angiofibromas Management in Tuberous Sclerosis
by: Giuseppe Lodi, et al.
Published: (2024)